Support The Moscow Times!

Takeda Gets License

Japanese pharmaceuticals company Takeda secured a production license for its factory in Yaroslavl, the company announced last week, Interfax reported. Construction was completed in September 2012.

The factory can produce drugs in solid and liquid form, including sterile solutions for injection, pills with various coatings and uncoated pills.

Under the license, the factory can manufacture both Takeda's own drugs and those of other companies with which it has contracts. The factory is expected to initially produce 90 million sterile ampoules and vials and more than 2 billion pills per year.

Takeda plans to begin packaging injection drugs this summer and begin full production at the start of 2014. The company invested 75 million euros ($98 million) in the facility, which is in the Yaroslavl pharmaceuticals cluster.

(MT)

Read more

Independent journalism isn’t dead. You can help keep it alive.

The Moscow Times’ team of journalists has been first with the big stories on the coronavirus crisis in Russia since day one. Our exclusives and on-the-ground reporting are being read and shared by many high-profile journalists.

We wouldn’t be able to produce this crucial journalism without the support of our loyal readers. Please consider making a donation to The Moscow Times to help us continue covering this historic time in the world’s largest country.